Tempo reale stimato
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,575 EUR | +1,15% | -4,41% | -20,25% |
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Jacob Chacko
CEO | Chief Executive Officer | 45 | 07/05/18 |
Richard Heyman
FOU | Founder | 66 | 01/01/14 |
Director of Finance/CFO | 50 | 01/09/19 | |
Lori Friedman
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/07/19 |
Edna Maneval
CTO | Chief Tech/Sci/R&D Officer | 64 | 01/03/19 |
Pratik Multani
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/18 |
Dan Iazzetti
HRO | Human Resources Officer | - | 01/09/22 |
Matthew Panuwat
PRN | Corporate Officer/Principal | 47 | 01/11/18 |
General Counsel | 51 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Angie You
BRD | Director/Board Member | 51 | 09/11/21 |
Richard Heyman
FOU | Founder | 66 | 01/01/14 |
Mardi Dier
BRD | Director/Board Member | 60 | 02/03/20 |
Lori Kunkel
BRD | Director/Board Member | 66 | 09/06/20 |
Jacob Chacko
CEO | Chief Executive Officer | 45 | 07/05/18 |
Steven Hoerter
BRD | Director/Board Member | 53 | 13/08/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 67 422 307 | 60 981 029 ( 90,45 %) | 0 | 90,45 % |
Coordinate società
Oric Pharmaceuticals, Inc.
240 East Grand Avenue 2nd Floor
94080, South San Francisco
+650 388 5600
http://www.oricpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+15,20% | 121 Mrd | |
+19,67% | 113 Mrd | |
+17,41% | 26,02 Mrd | |
-23,86% | 19,39 Mrd | |
-18,89% | 15,91 Mrd | |
-20,90% | 15,09 Mrd | |
-46,14% | 15,06 Mrd | |
+63,85% | 14,93 Mrd | |
+4,49% | 13,85 Mrd |
- Borsa valori
- Azioni
- Azione ORIC
- Azione 4TZ
- Società ORIC Pharmaceuticals, Inc.